Rebecca Shatsky: Don’t you think it’s a red flag if someone prescribes ALL cancer patients the same thing?
Rebecca Shatsky shared a post on X:
“Seeing SO many patients taking ivermectin, fenbendazole, IV artusenate for their cancer prescribed by “functional medicine” doctors. I do not understand why everyone falls for this. Don’t you think it’s a red flag if someone prescribes ALL cancer patients the same thing?
Cancer is NOT one disease! It is a thousand different diseases and each cancer is unique actually. Anyone with actual knowledge or training in cancer would NEVER recommend the same treatment for someone with lymphoma as for someone with breast cancer!
Please stop giving these charlatans your hard-earned money! Check the credentials of who you see. They should have completed a 3-year internal medicine residency and 2-3 yr oncology fellowship AND be board certified in oncology. Otherwise, they do not know how to treat cancer.
I call these people “cancer vultures.” They sweep in to make a profit by selling useless and dangerous junk with zero real evidence supporting its use (and you better believe this nonsense is 100% out of pocket) and empty your wallet when you’re at your most vulnerable.”
Source: Rebecca Shatsky/X
Rebecca Shatsky is an Associate Professor at UC San Diego Health, Breast Medical Oncology Co-Team Leader, Scientific Director of the Inflammatory and Triple Negative Breast Cancer Program. She is a member of the NCCN guideline panel for Genetic/High-Risk Assessment of Breast, Ovarian and Pancreatic Cancer and the panel for the treatment of Cancer-Associated Pain.
Her work has been published in JAMA Oncology, Cancer Cell and Molecular Cancer Therapeutics, among others. Dr. Shatsky is a member of the American Association for Cancer Research and the American Society of Clinical Oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023